High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

DOI Full Paper Access

129

Citations

23

References

2021

Year

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, Odd Terje Brustugun, Kjersti Hornslien, Tesfaye Madebo, Seppo W. Langer, Tine Schytte, Jan Nyman, Signe Risum,

The Lancet Oncology

Adaptive RadiotherapyOncologyRadiation TherapyMedicineRadiation OncologyLung Cancer

References

	Year	Citations

Page 1